Cargando…
Conotoxin MVIIA improves cell viability and antioxidant system after spinal cord injury in rats
This study evaluates whether intrathecal MVIIA injection after spinal cord injury (SCI) elicits neuroprotective effects. The test rats were randomly distributed into six groups— sham, placebo, MVIIA 2.5 μM, MVIIA 5 μM, MVIIA 10 μM, and MVIIA 20 μM—and were administered the treatment four hours after...
Autores principales: | Oliveira, Karen M., Binda, Nancy S., Lavor, Mário Sérgio L., Silva, Carla M. O., Rosado, Isabel R., Gabellini, Endrigo L. A., Da Silva, Juliana F., Oliveira, Camila M., Melo, Marília M., Gomez, Marcus Vinícius, Melo, Eliane G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171875/ https://www.ncbi.nlm.nih.gov/pubmed/30286181 http://dx.doi.org/10.1371/journal.pone.0204948 |
Ejemplares similares
-
Systemic effects induced by intralesional injection of ω-conotoxin MVIIC after spinal cord injury in rats
por: Oliveira, Karen M, et al.
Publicado: (2014) -
ω-Conotoxins GVIA, MVIIA and CVID: SAR and Clinical Potential
por: Schroeder, Christina I., et al.
Publicado: (2006) -
TAT-Modified ω-Conotoxin MVIIA for Crossing the Blood-Brain Barrier
por: Yu, Shuo, et al.
Publicado: (2019) -
Self-Assembly Nanostructure of Myristoylated ω-Conotoxin MVIIA Increases the Duration of Efficacy and Reduces Side Effects
por: Ding, Xiufang, et al.
Publicado: (2023) -
Analgesic effect of recombinant GABAergic precursors releasing ω-conotoxin
MVIIA in a model of peripheral nerve injury in rats
por: Jergova, Stanislava, et al.
Publicado: (2022)